Kohler, Sven <br/><br/>
Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes: Pooled Analysis of Phase I-III Clinical Trials.  [electronic resource] 

 -  Advances in therapy  07 2017 
 - 1707-1726 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1865-8652 
<br/><br/><label>Standard No.: </label>10.1007/s12325-017-0573-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Benzhydryl Compounds--adverse effects<br/>Clinical Trials, Phase I as Topic<br/>Clinical Trials, Phase II as Topic<br/>Clinical Trials, Phase III as Topic<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Dose-Response Relationship, Drug<br/>Drug-Related Side Effects and Adverse Reactions--etiology<br/>Female<br/>Glucosides--adverse effects<br/>Humans<br/>Hypoglycemic Agents--adverse effects<br/>Incidence<br/>Male<br/>Middle Aged<br/>Randomized Controlled Trials as Topic<br/>Sulfonylurea Compounds--therapeutic use